GlucoTrack, Inc. GCTK
Set alert
0.49 USD -0.31 -38.75%
As of Nov 2, 3:47 PM ET
0.49 Day range 0.7604
0.49 52-week range 207.00
- YTD
- -99.58%
- 1 year
- -99.75%
- Open
- 0.76
- Prev close
- 0.80
- Mkt cap
- 580.22K
- Vol
- 73.95K
- Avg vol
- 1.90M
- EPS
- -149.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.49
- High
- 0.7604
- Forward P/E
- 0.00
- Beta
- 0.16
- Short ratio
- 6.03
- Inst. own
- 0.95%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.97332
- 200-d avg
- 1.89
- 1y target
- 0.00
3M chart
Events in this range
- Aug 31, 2026Split: 1 for 15
- Oct 26, 2026Split: 1 for 2
Signals (13)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 2026 | 15 hours ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
Key statistics
- Market cap
- 3.83M
- Enterprise value
- 1.60M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.35
- EPS (TTM)
- -2.91
- Beta
- 0.16
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -4.69M
- Total cash
- 159.00K
- Total debt
- 274.00K
- Return on equity
- -541.13%
- Shares outstanding
- 14.49M
- Short % of float
- 0.83%
- 50-day average
- 0.97332
- 200-day average
- 1.89
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
GCTK Revenue — quarterly 0
GCTK Net income — quarterly -3.81M
GCTK EPS — quarterly -22.80
About GlucoTrack, Inc.
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- glucotrack.com
News
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Glucotrack, Inc. Announces Reverse Stock Split
- Glucotrack’s Subsidiary Lōkahi Therapeutics Unveils Qare Comparative Health Platform For GLP-1 And Other Treatment Outcomes
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
- Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
Your note
Sign in to keep a note on GCTK — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| SYCOFF ANDREW | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 21, 2024 | 2,951,260 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.47% | 27,161 | 7.17K | Sep 29, 2024 |
| Alerus Financial NA | 0.24% | 13,855 | 3.66K | Sep 29, 2024 |
| Cetera Investment Advisers | 0.17% | 10,000 | 2.64K | Sep 29, 2024 |
| UBS Group AG | 0.05% | 3,085 | 814 | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.01% | 432 | 114 | Sep 29, 2024 |
| Morgan Stanley | 0.01% | 500 | 131 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.37% | 21,613 | 5.71K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.09% | 5,064 | 1.34K | Oct 30, 2024 |